IgA glycosylation in IgA nephropathy

Advances in Experimental Medicine and Biology

Volumn 435, Issue , 1998, Pages 175-183

  Allen, Alice ^a   Feehally, John ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

AMINO ACID SEQUENCE; ANAPHYLACTOID PURPURA; ANIMAL; BINDING SITE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MOLECULAR SEQUENCE DATA; PURPURA, SCHOENLEIN-HENOCH;

EID: 0031614142     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5383-0_17     Document Type: Article

References (36)

1. G d'Amico. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med, 245:709 (1987).
2. G d'Amico. Clinical features and natural history in adults with IgA nephropathy. A J Kidney Dis, 12:353 (1988).
3. FB Waldo. Is Henoch-Schönlein purpura the systemic form of IgA nephropathy?. Am J Kidney Dis, 12:373 (1988).
4. J Feehally. Immune mechanisms in glomerular IgA deposition. Nephrol Dial Transplant, 3:361 (1988).
5. M-C Béné, G Faure. Mesangial IgA in IgA nephropathy arises from the mucosa. Am J KidneyDis, 12:406 (1988).
6. L Layward, AC Allen, SJ Harper, JM Hattersley, J Feehally. Increased and prolonged production of specific polymeric IgA after systemic immunisation with tetanus toxoid in IgA nephropathy. Clin Exp Immunol, 88:394 (1992).
7. L Layward, AC Allen, JM Hattersley, SJ Harper, J Feehally. Elevation of IgA in IgA nephropathy is localised in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant, 8:25 (1993).
8. SJ Harper, JH Pringle, ACB Wicks, J Hattersley, L Layward, AC Allen, A Gillies, I Lauder, J Feehally. Expression of J chain mRNA in duodenal plasma cells in IgA nephropathy. Kidney Int, 45:836 (1994).
9. SJ Harper, AC Allen, JH Pringle, J Feehally. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy. J Clin Pathol, 49:38 (1996).
10. SN Emancipator, ME Lamm. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest, 60:168 (1989).
11. M-C Béné, P Canton, C Amiel, T May, G Faure. Absence of mesangial IgA in AIDS: a postmortem study. Nephron, 58:425 (1991).
12. V Montinaro, AR Esparza, T Cavallo, A Rifai. Antigen as mediator of glomerulr injury in experimental IgA nephropathy. Lab Invest, 64:508 (1991).
13. J Mestecky. Immunobiology of IgA. Am J Kidney Dis, 12:378 (1988).
14. J Baenziger, S Kornfeld. Structure of the carbohydrate units of IgA1 immunoglobulin. II, Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem, 249:7270 (1974).
15. MC Field, RA Dwek, CJ Edge, TW Rademacher. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans, 17:1034 (1989).
16. MA Kerr. The structure and function of human IgA. Biochem J, 271:285 (1990).
17. Z Moldoveanu, I Moro, J Radl, SR Thorpe, K Komiyama, J Mestecky. Site of catabolism of autologous and heterologous IgA in non-human primates. Scand J Immunol, 32:577 (1990).
18. RJ Stockert, MS Kressner, JC Collins, I Sternlieb, AG Morell. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA, 79:6229 (1982).
19. N Jentoft. Why are proteins O-glycosylated? Trends in Biochemical Sciences, 15:291 (1990).
20. EF Hounsell, MJ Davies. Role of protein glycosylation in immune regulation. Annals Rheumatic Dis, 52:822 (1993).
21. H Lis, N Sharon. Protein glycosylation. Structural and functional aspects. Eur J Biochem, 218:1 (1993).
22. C Gomez-Guerrero, E Gonzalez, J Egido. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol, 151:7172 (1993).
23. AC Allen, MR Greer, C Combe, WW Stewart, SJ Harper, MA Kerr, J Feehally. Binding of human IgA to human leucocytes and mesangial cells. J Am Soc Nephrol, 5:739 (1994).
24. AC Allen, SJ Harper, J Feehally. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol, 100:470 (1995).
25. AC Allen, F Willis, SJ Harper, TJ Beattie, J Feehally. Altered O-glycosylation of IgA1 in Henoch-Schönlein purpura is restricted to subjects with nephritis. Nephrol Dial Transplant, in press (1996).
26. PM Andre, P le Pogamp, D Chevet. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal, 4:115 (1990).
27. Y Hiki, H Iwase, M Saitoh, Y Saitoh, A Horii, K Hotta, Y Kobayashi. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron, 72:429 (1996).
28. J Mestecky, M Tomana, PA Crowley-Nowick, Z Moldoveanu, BA Julian, S Jackson. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol, 104:172 (1993).
29. R Coppo, A Amore, B Gianoglio, A Reyna, L Peruzzi, D Roccatello, D Alessi, LM Sena. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol, 104:162 (1993).
30. D Baharaki, M Dueymes, R Perrichot, C Basset, R Lecorre, J Cledes, P Youinou. Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconjugate J, 13:505 (1996).
31. JS Axford, N Sumar, A Alavi, DA Isenberg, A Young, KB Bodman, IM Roitt. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest, 89:1021 (1992).
32. LT Lee, S Frank, DS de Jongh, C Howe. Immunochemical studies on Tn erythrocyte glycoprotein. Blood, 58:1228 (1981).
33. Y Hiki, H Iwase, T Kokubo, A Horii, A Tanaka, J Nishikido, K Hotta, Y Kobayashi. Association of asialo-galactosylβ1-3N-acetylgalactosamine on the hinge with a conformational instability of jacalin-reactive immunoglobulin Al in immunoglobulin A nephropathy. J Am Soc Nephrol, 7:955 (1996).
34. M Matsuda, Y Mishige, K Takenouchi, T Tabe, A Moriyama, T Haruta, Y Ohtsubo, Y Uchida, Y Yasumoto, T Arima. Amino acid sequence of the hinge region of IgA1 molecule can not be responsible for defective galactosylation in patients with IgA nephropathy. J Am Soc Nephrol, 7:1323 (1996).
35. JU Baenziger. Protein-specific glycosyltransferases: how and why they do it! FASEB J, 8:1019 (1994).
36. AC Allen, PS Topham, SJ Harper, J Feehally. Reduced β1,3 galactosyltransferase activity in the B cells of patients with IgA nephropathy. J Am Soc Nephrol, 6:820 (1995).